Single-center experience with pegfilgrastim (P) and lenograstim (L) in nonmetastatic breast cancer (NMBC) patients (pts) during adjuvant FEC100 or sequential FEC100 plus DOCETAXEL100 (D100).
ANSELMO PAPA
No relevant relationships to disclose
Luigi Rossi
No relevant relationships to disclose
Davide Caruso
No relevant relationships to disclose
Federica Tomao
No relevant relationships to disclose
Giulia Rinaldi
No relevant relationships to disclose
Eleonora Zaccarelli
No relevant relationships to disclose
Erika Giordani
No relevant relationships to disclose
Monica Verrico
No relevant relationships to disclose
Martina Strudel
No relevant relationships to disclose
Gian Paolo Spinelli
No relevant relationships to disclose
Carlo Capalbo
No relevant relationships to disclose
Giuseppe Lo Russo
No relevant relationships to disclose
Salvatore Evangelista
No relevant relationships to disclose
Fabio Ricci
No relevant relationships to disclose
Francesca Perrone-Congedi
No relevant relationships to disclose
Loredana Bianchi
No relevant relationships to disclose
Valeria Stati
No relevant relationships to disclose
Alessandra Anna Prete
No relevant relationships to disclose
Silverio Tomao
No relevant relationships to disclose